Jantoven and Skin blushing/flushing - a phase IV clinical study of FDA data

Summary:

Skin blushing/flushing is reported as a side effect among people who take Jantoven (warfarin sodium), especially for people who are female, 30-39 old, also take Coumadin, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Skin blushing/flushing when taking Jantoven. It is created by eHealthMe based on reports of 1,546 people who have side effects when taking Jantoven from the FDA, and is updated regularly.

What is Jantoven?

Jantoven has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 1,608 Jantoven users. Check the latest studies of Jantoven.

What is Skin blushing/flushing?

Skin blushing/flushing (a sudden reddening of the face, neck) is found to be associated with 2,009 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Skin blushing/flushing.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 13, 2026

1,546 people reported to have side effects when taking Jantoven.
Among them, 23 people (1.49%) have Skin blushing/flushing.

Could Jantoven cause Skin blushing/flushing?

Among these 23 people:

What is the gender of people who have Skin blushing/flushing when taking Jantoven? *

female: 65.22 %
male: 34.78 %

What is the age of people who have Skin blushing/flushing when taking Jantoven? *

What are other drugs people take besides Jantoven? *

What are other side effects people have besides Skin blushing/flushing? *

Headache (pain in head): 12 people, 52.17%
Nausea (feeling of having an urge to vomit): 12 people, 52.17%
Abdominal Discomfort: 9 people, 39.13%
Diarrhea: 9 people, 39.13%
Fainting (loss of consciousness and postural tone): 8 people, 34.78%
Pain In Jaw: 8 people, 34.78%
Application Site Pruritus (application site severe itching of the skin): 7 people, 30.43%
Dermatitis Contact (skin reaction (dermatitis) resulting from exposure to allergens): 7 people, 30.43%
Catheter Site Erythema (redness of skin at catheter site): 7 people, 30.43%
Nasopharyngitis (inflammation of the nasopharynx): 7 people, 30.43%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 13 people, 56.52%
Multiple Myeloma (cancer of the plasma cells): 3 people, 13.04%
Low Density Lipoprotein Increased (cholesterol increased in blood): 2 people, 8.70%
High Blood Cholesterol: 2 people, 8.70%
Type 2 Diabetes: 1 person, 4.35%
Neuropathy Peripheral (surface nerve damage): 1 person, 4.35%
Neck Pain: 1 person, 4.35%
Nausea (feeling of having an urge to vomit): 1 person, 4.35%
Ill-Defined Disorder: 1 person, 4.35%
Diabetes: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Jantoven and have Skin blushing/flushing?

- Check whether Skin blushing/flushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Jantoven:

Jantoven (1,608 reports)

Browse all side effects of Jantoven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,009 drugs)

Browse all the conditions that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,936 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium (the active ingredients of Jantoven) and Jantoven (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.